AA Financial News  
Top
Popular
Latest
Top
<Research> BofAS Lowers Postal Savings Bank of China TP to HKD4.65, Rating 'Underperform'
0
0
0
<Research> G Sachs Lowers TP for WEIGAO GROUP to HKD6, Maintains 'Buy' Rating
0
0
1
<Research> G Sachs Lowers TP for LONGFOR to HKD8.6, Expects Continued Pressure on Development Business
0
0
0
<Research> Citi Raises TSMC Earnings Forecast, Expects AI-Related Revenue to Double Next Year
0
1
0
<Research> Citi: ICBC 4Q Results Slightly Below Expectations, Dividend Attractive
1
6
2
BYD COMPANY Confident in Achieving This Yr's 1.5M Car Export Target, Higher Than Previous Expectations: Wire
2
7
2
<Research> UBS Expects ICBC to Maintain Stable Performance Last Year with TP at HKD7.79
4
8
1
State Administration for Market Regulation: Prevent Large Enterprises from Delaying Payments to SMEs
0
1
2
National Market Supervision Administration: Research and Formulate 'Prohibition of Unfair Online Competition Regulations'
0
1
4
CN SAMR: Balance Data Protection and Utilization, Enhance Protection for Emerging Industries like AI
45
70
38
CN SAMR: CN to Focus on Preventing 'Involutionary' Competition in Key Sectors & Areas Like Platform Econ/ Photovoltaics/ Lithium Batteries/ NEVs
40
84
30
SHENZHOU INTL Slips 5%+ as 2025 Profit Sags 6.7%, Final DPS Reduced
2
4
5
Lionel Messi Files Lawsuit in New York Court Against Sellers on Temu, Shein, and Walmart Platforms for Infringement
1
2
2
<Asia> Asia-Pacific Markets Mostly Decline; Japanese and South Korean Markets See Significant Drops; Australian Bank Stocks Under Pressure
1
0
2
Stanchart's CIO of North Asia, Raymond Cheng: Base Case Scenario Assumes 70% Chance of Oil Price Peaking in Wks; HSI May Rebound to 28,000-29,000 in 12 Mths
1
0
5
<Research>G Sachs Trims Targets for MSCI China Index/ CSI 300 Index by 5%/ 4%, Still Recommends Overweight on A-/ H-Shrs
4
2
5
<Research> Nomura Raises TP for HAIDILAO to HKD18.4, Expects Multiple Positive Factors This Year
3
3
2
<Research>Nomura Chops MEITUAN-W TP to $92 as Competitive Landscape Remains Unclear
5
3
5
<Research>HSBC Research Lowers TP of CHINA LIFE to HKD26 Due to Limited Earnings Visibility
6
2
6
<Research> UBS Lowers TP of CHINA BIOPHARMACEUTICAL to HKD11, Rating 'Buy'
3
6
4
  • Remark
  • (1) HK Indices are real time
Home|RT Quote|Market|News|Indices
Feedback|Disclaimer
View: Mobile|Desktop
Lang: 繁|简|EN
Back To Top
Contact Us
Email: support@aastocks.com